Grant: Collaborative Research and Training Experience
York University
$150,000.00
Technology-Enhanced Pharmaceutical Discovery (TEPD)
FY 2023-24
Summary
capillary electrophoresis; combinatorial libraries; DNA-encoded library technology; drug discovery; high-throughput screening; hit-to-lead process; hit validation; mass spectrometry; vaccine development
Program
Collaborative Research and Training Experience
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
575259-2023
Name nom
Krylov, Sergey SN
Department département
Chemistry
Organization id
38
Institution établissement
York University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
150000
Program id
CREAT
Program name en
Collaborative Research and Training Experience
Program name fr
Programme de formation orientée vers la nouveauté, la collaboration et l'expérience en recherche
Group en
RESEARCH TRAINING AND TALENT DEVELOPMENT
Group fr
FORMATION EN RECHERCHE ET PERFECTIONNEMENT DES COM
Committee code
1078
Committee name en
CREATE Program
Committee name fr
Programme FONCER
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Organic syntheses
Research subject en
Chimie organique
Research subject fr
Synthèses organiques
Application title
Technology-Enhanced Pharmaceutical Discovery (TEPD)
Keyword
capillary electrophoresis; combinatorial libraries; DNA-encoded library technology; drug discovery; high-throughput screening; hit-to-lead process; hit validation; mass spectrometry; vaccine development
Application summary
capillary electrophoresis; combinatorial libraries; DNA-encoded library technology; drug discovery; high-throughput screening; hit-to-lead process; hit validation; mass spectrometry; vaccine development
